Table 2.
Type | Cell line | Endoglin expression | BMP-9 signaling | TGF-β signaling | Cell migration | Cell proliferation |
---|---|---|---|---|---|---|
ESCC | TE01 | High | ENG KO ↔ | ENG KO ↔ | ENG KO ↔ | ENG KO ↔ |
ESCC | TE10 | Low | ENG OE ↓ | ENG OE ↔ | ENG OE ↔ | ENG OE ↓ |
ESCC | TE11 | Low | ENG OE ↓ | ENG OE ↔ | ENG OE ↔ | ENG OE ↔ |
VSCC | VC415-C | Low | TRC105 ↓ | TRC105 ↔ | ND | ND |
VSCC | VC415-S | High | TRC105 ↓ | TRC105 ↔ | ENG KD ↔ | ENG KD ↔ |
HNSCC | OSC-19 | Moderate | TRC105 ↔ | ND | TRC105 ↔ | ND |
HNSCC | FaDu | High | TRC105 ↔ | ND | TRC105 ↔ | ND |
ENG, endoglin; KO, knockout; OE, overexpression; TRC015, endoglin neutralizing antibody; KD, knockdown; ND, not determined; ↔ = no effect, ↓ = decrease.